Cocrystal Pharma (COCP) Intangibles (2011 - 2013)

Cocrystal Pharma (COCP) has 3 years of Intangibles data on file, last reported at $162616.0 in Q2 2013.

• For the quarter ending Q2 2013, Intangibles fell 25.8% year-over-year to $162616.0; the trailing twelve-month figure through Jun 2013 stood at $162616.0 (down 25.8% YoY), and the FY2012 full-year result was $190894.0, down 22.86% from the prior year.
• Intangibles declined to $162616.0 in Q2 2013, from $176755.0 in the prior quarter.
• In the past five years, Intangibles ranged from a high of $247450.0 in Q4 2011 to a low of $162616.0 in Q2 2013.
• A 3-year average of $205033.0 and a median of $205033.0 in 2012 frame the typical range for Intangibles.
• Across the five-year window, Intangibles dropped 22.86% in 2012 and retreated 25.8% in 2013, its largest moves.
• Tracing COCP's Intangibles over 3 years: stood at $247450.0 in 2011, then decreased by 22.86% to $190894.0 in 2012, then dropped by 14.81% to $162616.0 in 2013.
• Business Quant data shows COCP's Intangibles at $162616.0 in Q2 2013, $176755.0 in Q1 2013, and $190894.0 in Q4 2012.